摘要
分析了欧美国家近20年吸入气雾剂(MDIs)中抛射剂替代的技术、法规、监管的经验和教训;总结了抛射剂替代后MDIs临床前研究的重点考察项目和成品质控的具体要求;介绍了国外MDIs的分类和单个品种与整个类别的淘汰策略。
This paper reviews the technology, quality control and regulations for altemative propellant MDIs in the USA and Europe in the past 20 years and summarizes the main pharmaceutical tests during pre-clinical development and specifications for HFA-MDIs products. The MDIs medication categories, strategies and current status for phase-out of CFC-MDIs abroad are introduced.
出处
《中国医药工业杂志》
CAS
CSCD
北大核心
2009年第7期543-548,共6页
Chinese Journal of Pharmaceuticals
关键词
吸入气雾剂
抛射剂替代
质控技术
淘汰策略
metered dose inhalers
propellant replacement
quality control
phase-out strategy